Lixte Biotechnology (LIXT) Institutional Ownership $1.18 -0.04 (-3.34%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:LIXT)CurrentInstitutional OwnershipPercentage5.10%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$314.53KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$65.81K Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LIXT Institutional Buying and Selling by Quarter Lixte Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025 FNY Investment Advisers LLC107,000$129K0.1%+172.8%3.396% 2/11/2025TIAA Trust National Association101,834$207K0.0%N/A4.526% 1/31/2025Atlas Legacy Advisors LLC12,707$26K0.0%N/A0.565% 1/13/2025 FNY Investment Advisers LLC39,219$82K0.0%-45.3%1.744% 6/5/2023EP Wealth Advisors LLC2,211$786K0.0%N/A0.013% 2/9/2023Ethos Financial Group LLC248,084$126K0.0%N/A1.490% 8/12/2022Almanack Investment Partners LLC.248,084$185K0.0%-66.7%1.490% 11/9/2021BlackRock Inc.13,425$28K0.0%+191.9%0.098% 11/4/2021Almanack Investment Partners LLC.806,050$1.68M0.1%-17.9%5.863% 8/16/2021State Street Corp33,600$102K0.0%N/A0.244% 8/16/2021Sabby Management LLC65,511$199K0.0%-17.8%0.477% 8/13/2021Renaissance Technologies LLC50,900$154K0.0%N/A0.370% 8/13/2021Vanguard Group Inc.74,383$225K0.0%N/A0.544% 8/4/2021Almanack Investment Partners LLC.982,046$2.98M0.3%-5.8%7.189% 5/21/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/18/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/11/2021Almanack Investment Partners LLC.1,042,105$3.43M0.3%N/A7.698% (Data available from 1/1/2016 forward) LIXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LIXT shares? During the previous two years, the following institutional investors and hedge funds held shares of Lixte Biotechnology shares: EP Wealth Advisors LLC ($786K), TIAA Trust National Association ($207K), and FNY Investment Advisers LLC ($129K), Atlas Legacy Advisors LLC ($26K).Learn more on LIXT's institutional investors. What percentage of Lixte Biotechnology stock is owned by institutional investors? 5.10% of Lixte Biotechnology stock is owned by institutional investors. Learn more on LIXT's institutional investor holdings. Which institutional investors have been buying Lixte Biotechnology stock? The following institutional investors have purchased Lixte Biotechnology stock in the last 24 months: TIAA Trust National Association ($101.83K), FNY Investment Advisers LLC ($67.78K), Atlas Legacy Advisors LLC ($12.71K), and EP Wealth Advisors LLC ($2.21K). How much institutional buying is happening at Lixte Biotechnology? Institutional investors have bought a total of 184,533 shares in the last 24 months. This purchase volume represents approximately $332.82K in transactions. Which Lixte Biotechnology major shareholders have been selling company stock? The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: FNY Investment Advisers LLC ($32.42K). How much institutional selling is happening at Lixte Biotechnology? Institutional investors have sold a total of 32,419 shares in the last 24 months. This volume of shares sold represents approximately $65.81K in transactions. Related Companies QNTM Major Shareholders IMNN Major Shareholders INAB Major Shareholders BGXX Major Shareholders CLRB Major Shareholders GLYC Major Shareholders SPRB Major Shareholders MBRX Major Shareholders LPTX Major Shareholders MRKR Major Shareholders This page (NASDAQ:LIXT) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.